quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:26:12·931d
SECFiling
Sorrento Therapeutics Inc. logo

Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SRNE· Sorrento Therapeutics Inc.
Health Care
Original source

Companies

  • SRNE
    Sorrento Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 2UpdateCantor Fitzgerald$5.00
  • Aug 9UpdateHC Wainwright & Co.$26.00

Related

  • PR447d
    Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
  • SEC898d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
  • SEC902d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
  • SEC940d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Regulation FD Disclosure, Other Events
  • SEC954d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC969d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
  • SEC976d
    Sorrento Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC986d
    SEC Form 10-Q filed by Sorrento Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022